LNTH Jan 2025 57.500 call
| Previous close | 14.40 |
| Open | 14.40 |
| Bid | 25.80 |
| Ask | 27.80 |
| Strike | 57.50 |
| Expiry date | 2025-01-17 |
| Day's range | 14.40 - 14.40 |
| Contract range | N/A |
| Volume | |
| Open interest | 56 |
ZacksAre You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ZacksAre Medical Stocks Lagging Lantheus (LNTH) This Year?
Here is how Lantheus Holdings (LNTH) and Agios Pharmaceuticals (AGIO) have performed compared to their sector so far this year.
GlobeNewswireLantheus to Present at the William Blair 44th Annual Growth Stock Conference
BEDFORD, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Paul Blanchfield, President, will present at the William Blair 44th Annual Growth Stock Conference at 2:40 p.m. CT on Tuesday, June 4. To access a live webcast of the presentation, please visit the Investors section of the Company’
